Literature DB >> 20308087

A case of recurred hepatocellular carcinoma refractory to doxorubicin after liver transplantation showing response to herbal medicine product, Rhus verniciflua Stokes extract.

Kyung Seok Kim1, Hyun Sik Jung, Won Cheol Choi, Wan Kyu Eo, Seong Ha Cheon.   

Abstract

There is no established protocol proven to be beneficial for treatment of hepatocellular carcinoma recurrence after liver transplantation. Only a few reports have shown direct treatment by surgery or ablation to be independent predictors of survival for localized recurrence. Moreover, the necessity of immunosuppression to prevent allograft rejection makes many physicians hesitate to administer systemic chemotherapy. This case report documents a case in which the administration of an herbal product, an extract of the lacquer tree, Rhus verniciflua Stokes, was associated with a decrease in the size of lung metastases in a patient with recurrent hepatocellular carcinoma after liver transplantation refractory to doxorubicin. This patient experienced prolonged survival compared with average survival times and little toxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308087     DOI: 10.1177/1534735409359772

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  7 in total

Review 1.  Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.

Authors:  Nicola de'Angelis; Filippo Landi; Maria Clotilde Carra; Daniel Azoulay
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 2.  Rhus verniciflua stokes against advanced cancer: a perspective from the Korean Integrative Cancer Center.

Authors:  Woncheol Choi; Hyunsik Jung; Kyungsuk Kim; Sookyung Lee; Seongwoo Yoon; Jaehyun Park; Sehyun Kim; Seongha Cheon; Wankyo Eo; Sanghun Lee
Journal:  J Biomed Biotechnol       Date:  2011-11-17

Review 3.  Integrating traditional medicine into modern inflammatory diseases care: multitargeting by Rhus verniciflua Stokes.

Authors:  Ji Hye Kim; Yong Cheol Shin; Seong-Gyu Ko
Journal:  Mediators Inflamm       Date:  2014-06-12       Impact factor: 4.711

4.  Inhibition of Human Cytochrome P450 Enzymes by Allergen Removed Rhus verniciflua Stoke Standardized Extract and Constituents.

Authors:  Hyunsik Jung; Sanghun Lee
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-30       Impact factor: 2.629

5.  Significance of serum ferritin as a prognostic factor in advanced hepatobiliary cancer patients treated with Korean medicine: a retrospective cohort study.

Authors:  Anna Song; Wankyu Eo; Sehyun Kim; Bumsang Shim; Sookyung Lee
Journal:  BMC Complement Altern Med       Date:  2018-06-07       Impact factor: 3.659

6.  Prolonged Progression-Free Survival in a Patient With Malignant Pleural Mesothelioma Following Korean Herbal Medicine Treatment Alone: A Case Report.

Authors:  Sung Soo Yoon; Eun Hye Kim; Jee Young Lee; Seong Woo Yoon
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279

7.  Impact of Standardized Allergen-Removed Rhus verniciflua Stokes Extract on Advanced Adenocarcinoma of the Ampulla of Vater: A Case Series.

Authors:  Woncheol Choi; Soomin An; Eunmi Kwon; Wankyu Eo; Sanghun Lee
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-22       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.